The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | N | Nervous system | |
| 2 | N01 | Anesthetics | |
| 3 | N01A | Anesthetics, general | |
| 4 | N01AH | Opioid anesthetics | |
| 5 | N01AH06 | Remifentanil |
| Active Ingredient | Description | |
|---|---|---|
| Remifentanil |
Remifentanil is a selective mu-opioid agonist with a rapid onset and very short duration of action. The mu-opioid activity, of remifentanil, is antagonised by narcotic antagonists, such as naloxone. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| FORTIVA Solution for injection | Health Products Regulatory Authority (ZA) | MPI, Generic | |
| ULTIVA Powder for concentrate for solution for infusion | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
